Tags: US | Bristol | Myers | Strategy

Bristol-Myers: 60 Drugs in Testing to Boost Sales

Thursday, 04 Mar 2010 01:24 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

Executives at drugmaker Bristol-Myers Squibb Co. are telling analysts at a business briefing they have 60 potential drugs in development, seven in late-stage studies.

The company says it expects future revenue from those medicines and growing sales from existing drugs to help offset an expected plunge in Plavix sales in 2012. That's when U.S. generic competition will start slashing sales of the $6 billion-a-year blood thinner, the world's second-best-selling drug.

The New York-based company's strategy aims to replace that revenue with new drug sales to maintain profits. Bristol-Myers forecasts earnings per share in 2013 will be at least $1.95, a little more than analysts expect.

The business briefing comes two days after news of a CEO change.

© Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Atheist Sues After New Jersey Rejects License Plate

Friday, 18 Apr 2014 22:31 PM

Shannon Moran, of Maurice River Township has filed a lawsuit against the state Motor Vehicle Commission, saying it viola . . .

South Carolina Mayor Fires Lesbian Police Chief

Friday, 18 Apr 2014 22:20 PM

A South Carolina mayor fired his 20-year veteran chief of police, who is a lesbian, reportedly declaring in a recorded p . . .

Discovery Channel Everest Jump in Doubt After Deadly Avalanche

Friday, 18 Apr 2014 22:12 PM

The Everest Jump Live special that Discovery Channel had planned for May 11 is in question following a deadly avalanch . . .

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved